Difference between revisions of "Team:Nagahama/Result and Discussion"

Line 543: Line 543:
 
First, we examined our working hypothesis to “Flavorator” that farnesol can show either the antibacterial or bacteriostatic activity in a box like “KOZOKO”.
 
First, we examined our working hypothesis to “Flavorator” that farnesol can show either the antibacterial or bacteriostatic activity in a box like “KOZOKO”.
  
−
The results clearly showed that farnesol had antibacterial properties.
+
The results clearly showed that farnesol had antibacterial properties.
  
−
In the literatures, farnesol have antibacterial volatiles.
+
In the literatures, farnesol have antibacterial volatiles.
  
 
Farnesol is produced after complicated pathways, so for their syntheses, various enzymes are required.
 
Farnesol is produced after complicated pathways, so for their syntheses, various enzymes are required.
Line 551: Line 551:
 
In E. coli, farnesol may be synthesized.
 
In E. coli, farnesol may be synthesized.
  
−
In this context, we designed our system for establishing the concept of “Flavorator” to build up a brand-new biosynthetic pathways, in which farnesol is produced in the E. coli.
+
In this context, we designed our system for establishing the concept of “Flavorator” to build up a brand-new biosynthetic pathways, in which farnesol is produced in the E. coli.
  
−
In doing so, we transfered the three types of genes listed below to create the hyper-producer E. coli of farnesol.
+
In doing so, we transfered the three types of genes listed below to create the hyper-producer E. coli of farnesol.
  
 
We examined our working hypothesis to “Flavorator” that farnesol can show either the antibacterial or bacteriostatic activity in a box like Kozoko.
 
We examined our working hypothesis to “Flavorator” that farnesol can show either the antibacterial or bacteriostatic activity in a box like Kozoko.

Revision as of 06:02, 16 October 2016

MENU ▤
　　

Confirmation antibacterial activity of farnesol.

First, we examined our working hypothesis to “Flavorator” that farnesol can show either the antibacterial or bacteriostatic activity in a box like “KOZOKO”.

The results clearly showed that farnesol had antibacterial properties.

In the literatures, farnesol have antibacterial volatiles.

Farnesol is produced after complicated pathways, so for their syntheses, various enzymes are required.

In E. coli, farnesol may be synthesized.

In this context, we designed our system for establishing the concept of “Flavorator” to build up a brand-new biosynthetic pathways, in which farnesol is produced in the E. coli.

In doing so, we transfered the three types of genes listed below to create the hyper-producer E. coli of farnesol.

We examined our working hypothesis to “Flavorator” that farnesol can show either the antibacterial or bacteriostatic activity in a box like Kozoko.



Confirmation of anti-mold, anti-maggots and antibocatrial activities of farnesol.